Complex treatment of locally advanced squamous cell carcinoma of the parotid gland and secondary primary melanoma

Alina Chelmuș, Liviu Dumitru Damian, Dragoș Pieptu, Codrin Nicolae Dobreanu

Abstract


Primary squamous cell carcinoma of the parotid gland accounts for 0.35% up to 9.8% of all parotid malignancies. In advanced stages, the gold standard is wide excision, lymphadenectomy and postoperative radiotherapy. Furthermore, head and neck cancers have an increased risk of secondary primary tumors development. Case report: A 82-year-old male underwent subtotal parotidectomy with facial nerve preservation for right parotid squamous cell carcinoma, in another department. Due to incomplete resection, 4 months later he presented with locoregional recurrence and cutaneous invasion. The patient underwent total parotidectomy en bloc with facial nerve, part of the external auditory meatus, posterior belly of digastric and part of sternocleidomastoid muscle with modified radical neck dissection, levels I-V. The defect was closed with ipsilateral pectoralis major myocutaneous flap, followed by a temporary lateral tarsorrhaphy after two months. The patient underwent adjuvant radiotherapy. One year after surgery, functional and aesthetic impairment of the facial nerve palsy were corrected: the lower face deficit by an orthodromic temporalis tendon transfer; lagophthalmos by lid loading with gold-weight. Postoperative outcome was satisfactory for the patient, with 3 years of postoperative evolution with no recurrence or metastasis. Concomitantly, the patient developed pT1a secondary primary melanoma on the skin island of the flap, which was excised. Conclusion: Patients with locoregional advanced parotid squamous cell carcinoma can benefit from wide excision with neck dissection and postoperative radiotherapy. When the facial nerve cannot be preserved, facial asymmetry can be improved through reanimation procedures. Secondary primary malignancies require proper treatment concomitantly with index tumor follow-up.


Keywords


parotid gland; squamous cell carcinoma; melanoma secondary tumor; facial reanimation; pectoralis major myocutaneous flap

Full Text:

PDF

References


Wang X, Luo Y, Li M, Yan H, Sun M, Fan T. Management of salivary gland carcinomas - a review. Oncotarget 2017; 8(3):3946-3956.

Mifsud MJ, Burton JN, Trotti AM, Padhya TA. Multidisciplinary management of salivary gland cancers. Cancer Control 2016; 23(3):242-248.

Thompson L. World Health Organization classification of tumours: pathology and genetics of head and neck tumours. Ear Nose Throat J 2006; 85:74.

Lee S, Kim GE, Park CS, et al. Primary squamous cell carcinoma of the parotid gland. Am J Otolaryngol 2001; 22(6):400-406.

National Comprehensive Cancer Network. Head and Neck Cancers. NCCN Clinical Practice Guidelines in Oncology. Version 2. 2017. [https://www.nccn.org/professionals/physician_gls/default.aspx available at 10/17/2018]

Jones AS, Morar P, Phillips DE, Field JK, Husband D, Helliwell TR. Second primary tumors in patients with head and neck squamous cell carcinoma. Cancer 1995; 75(6):1343-1353.

Morris LG, Sikora AG, Patel SG, Hayes RB, Ganly I. Second primary cancers after an index head and neck cancer: subsite-specific trends in the era of human papillomavirus-associated oropharyngeal cancer. J Clin Oncol 2011; 29(6):739-746.

Flynn MB, Maguire S, Martinez S, Tesmer T. Primary squamous cell carcinoma of the parotid gland: the importance of correct histological diagnosis. Ann Surg Oncol 1999; 6(8):768-770.

Giriyan S, Paragannavar V. Primary squamous cell carcinoma of parotid gland: common tumor at an uncommon site - a case report. Int J Sci Res 2015; 4(10):520-522.

Armstrong JG, Harrison LB, Thaler HT, et al. The indications for elective treatment of the neck in cancer of the major salivary glands. Cancer 1992; 69: 615-619.

Wei WI, Wei CY. Pectoralis Major Flap. In: Wei FC, Mardini S, editors. Flaps and reconstructive surgery. London: Elsevier, 2017; 396-415.

Liu M, Liu W, Yang X, Guo H, Peng H. Pectoralis major myocutaneous flap for head and neck defects in the era of free flaps: harvesting technique and indications. Sci Rep 2017; 7:46256.

Tripathi M, Parshad S, Karwasra RK, Singh V. Pectoralis major myocutaneous flap in head and neck reconstruction: An experience in 100 consecutive cases. Natl J Maxillofac Surg 2015; 6(1):37–41.

Patel K, Lyu DJH, Kademani D. Pectoralis major myocutaneous flap. Oral Maxillofacial Surg Clin N Am 2014; 26:421–426.

Sayan M, Vempati P, Miles B, et al. Adjuvant therapy for salivary gland carcinomas. Anticancer Res 2016; 36(8):4165-4170.

Nagliati M, Bolner A, Vanoni V, et al. Surgery and radiotherapy in the treatment of malignant parotid tumors: a retrospective multicenter study. Tumori 2009; 95(4):442-448.

Bell RB, Dierks EJ, Homer L, Potter BE. Management and outcome of patients with malignant salivary gland tumors. J Oral Maxillofac Surg 2005; 63(7):917-928.

Cederblad L, Johansson S, Enblad G, Engstrom M, Blomquist E. Cancer of the parotid gland; long-term follow-up. A single centre experience on recurrence and survival. Acta Oncol 2009; 48(4):549-555.

Terhaard CH, Lubsen H, Rasch CR, et al. The role of radiotherapy in the treatment of malignant salivary gland tumors. Int J Radiat Oncol Biol Phys 2005; 61(1):103-111.

Maria OM, Eliopoulos N, Muanza T. Radiation-induced oral mucositis. Front Oncol 2017; 7:89.

Muanza TM, Cotrim AP, McAuliffe M, Sowers AL, Baum BJ, Cook JA et al. Evaluation of radiation-induced oral mucositis by optical coherence tomography. Clin Cancer Res 2005; 11(14):5121–5127.

Sonis ST, Elting LS, Keefe D, et al. Perspectives on cancer therapy-induced mucosal injury. Cancer 2004; 100(Suppl. 9): 1995–2025.

Vásquez LM, Medel R. Lagophthalmos after facial palsy: current therapeutic options. Ophthalmic Res 2014; 52:165–169.

Pereira MVC, Glória ALF. Lagophthalmos. Semin Ophthalmol 2010; 25(3):72–78.

Leedy JE. Facial reanimation. In: Janis JE, editor. Essentials of Plastic Surgery. St. Louis, Missouri: Quality Medical Publishing, Inc., 2007; 347-361.

Kejner AE, Rosenthal EL. Lower facial reanimation techniques following cancer resection and free flap reconstruction. Laryngoscope 2016; 126(9):1990-1994.

Griffin GR, Abuzeid W, Vainshtein J, Kim JC. Outcomes following temporalis tendon transfer in irradiated patients. Arch Facial Plast Surg 2012; 14:395–402.

Liao LJ, Chou HW, Wang CT, Chung CS, Lai MS. The impact of second primary malignancies on head and neck cancer survivors: a nationwide cohort study. PLoS One 2013; 8(4):e62116.

Singh GK, Yadav V, Singh P, Bhowmik KT. Radiation-induced malignancies making radiotherapy a "two-edged sword": a review of literature. World J Oncol 2017; 8(1):1-6.




DOI: http://dx.doi.org/10.22551/2018.20.0503.10135

Copyright (c) 2018 Alina Chelmuș, Liviu Dumitru Damian, Dragoș Pieptu, Codrin Nicolae Dobreanu

Creative Commons License
Archive of Clinical Cases is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

 

ISSN: 2360-6975